0001493152-24-002527.txt : 20240116 0001493152-24-002527.hdr.sgml : 20240116 20240116190555 ACCESSION NUMBER: 0001493152-24-002527 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240112 FILED AS OF DATE: 20240116 DATE AS OF CHANGE: 20240116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KUMAR AMIT CENTRAL INDEX KEY: 0001191905 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37492 FILM NUMBER: 24536415 MAIL ADDRESS: STREET 1: C/O ACACIA RESEARCH CORPORATION STREET 2: 500 NEWPORT CENTER DRIVE, 7TH FLOOR CITY: NEWPORT BEACH STATE: CA ZIP: 92660 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anixa Biosciences Inc CENTRAL INDEX KEY: 0000715446 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 112622630 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 BUSINESS ADDRESS: STREET 1: 3150 ALMADEN EXPRESSWAY, SUITE 250 CITY: SAN JOSE STATE: CA ZIP: 95118 BUSINESS PHONE: 408-708-9808 MAIL ADDRESS: STREET 1: 3150 ALMADEN EXPRESSWAY, SUITE 250 CITY: SAN JOSE STATE: CA ZIP: 95118 FORMER COMPANY: FORMER CONFORMED NAME: ITUS Corp DATE OF NAME CHANGE: 20140902 FORMER COMPANY: FORMER CONFORMED NAME: COPYTELE INC DATE OF NAME CHANGE: 19920703 4 1 ownership.xml X0508 4 2024-01-12 0 0000715446 Anixa Biosciences Inc ANIX 0001191905 KUMAR AMIT C/O ANIXA BIOSCIENCES, INC. 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE, CA 95118 1 1 0 0 Chief Executive Officer 0 Employee Stock Option (Right to Buy) 4.39 2024-01-12 4 A 0 700000 0 A 2034-01-12 Common Stock 700000 700000 D Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan. The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2024. /s/ Amit Kumar 2024-01-16